These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23275896)

  • 1. Relationship between angiogenesis and lymphangiogenesis in recurrent pterygium.
    Qi CX; Zhang XD; Yuan J; Yang JZ; Sun Y; Wang T; Ye H; Ling SQ
    Int J Ophthalmol; 2012; 5(6):655-60. PubMed ID: 23275896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing lymphatic microvessel density in primary pterygia.
    Ling S; Liang L; Lin H; Li W; Xu J
    Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.
    Lin H; Luo L; Ling S; Chen W; Liu Z; Zhong X; Wu C; Chen W; Liu Y
    Mol Vis; 2013; 19():166-73. PubMed ID: 23378730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia.
    Zhao W; Wang T; Deng J; Zhong L; Huang W; Ling S
    J Ophthalmol; 2016; 2016():1592514. PubMed ID: 26941998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between lymphangiogenesis and the size of pterygium.
    Liu L; Ling SQ; Li QL; Wang T; Ye H; Yang JZ; Jia XH
    Int J Ophthalmol; 2012; 5(3):312-6. PubMed ID: 22773979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.
    Ling S; Li Q; Lin H; Li W; Wang T; Ye H; Yang J; Jia X; Sun Y
    Eye (Lond); 2012 Nov; 26(11):1451-8. PubMed ID: 22975656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
    Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
    Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors.
    Gao Y; Zhong WX; Mu DB; Yuan YP; Zhang YH; Yu JM; Sun LP; Wang L; Li YH; Zhang JB; Zhao Y; Cai SP; Zhou GY
    Ann Surg Oncol; 2008 Apr; 15(4):1117-23. PubMed ID: 18202892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphB4 expression in pterygium is associated with microvessel density.
    Xue C; Chen Y; Huang Z; Ge Y; Wang H; Wang J
    Int J Clin Exp Med; 2014; 7(11):4008-15. PubMed ID: 25550909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium.
    Cimpean AM; Poenaru Sava M; Raica M; Ribatti D
    Oncol Rep; 2011 Nov; 26(5):1111-3. PubMed ID: 21667034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nestin expression in pterygia: potential role in angiogenesis.
    Tonthat CV; Di Girolamo N
    Br J Ophthalmol; 2014 Jun; 98(6):801-7. PubMed ID: 24008823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium.
    Wang Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X
    Cornea; 2017 Jul; 36(7):841-844. PubMed ID: 28489720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study.
    Kawamura L; Carvalho FM; Alves BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    World J Surg Oncol; 2010 Oct; 8():89. PubMed ID: 20946633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression in primary and recurrent pterygium.
    Karahan N; Baspinar S; Ciris M; Baydar CL; Kapucuoglu N
    Indian J Ophthalmol; 2008; 56(4):279-83. PubMed ID: 18579985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative activity and p53 expression in primary and recurrent pterygia.
    Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
    Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium.
    Wang T; Peng R; Ni H; Zhong L; Zhang H; Wang T; Cheng H; Bao T; Jia X; Ling S
    Int Immunopharmacol; 2023 May; 118():110086. PubMed ID: 37030121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated lymphatic vessel density measured by Lyve-1 expression in areas of replacement fibrosis in the ventricular septum of patients with hypertrophic obstructive cardiomyopathy (HOCM).
    Jiang X; Cui J; Yang C; Song Y; Yuan J; Liu S; Hu F; Yang W; Qiao S
    Heart Vessels; 2020 Jan; 35(1):78-85. PubMed ID: 31250132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.
    Gumus K; Karakucuk S; Mirza GE; Akgun H; Arda H; Oner AO
    Br J Ophthalmol; 2014 Jun; 98(6):796-800. PubMed ID: 23376569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.
    Aspiotis M; Tsanou E; Gorezis S; Ioachim E; Skyrlas A; Stefaniotou M; Malamou-Mitsi V
    Eye (Lond); 2007 Aug; 21(8):1095-101. PubMed ID: 16823458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.